ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years

Beilei Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1384-0175; OpenAlex author ID A5081597958. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

LncRNAs-Regulated High Expression of LAMC2 Reveals a Prognostic and Immunological Value in Pancreatic Adenocarcinoma. Last author DOI 10.1007/s10528-023-10435-4 ↗
The role of FOLFIRINOX in metastatic pancreatic cancer: a meta-analysis. Co-author DOI 10.1186/s12957-021-02291-6 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jingyun Liu · 1 shared paper, 2024 · strength 0.28
- Paper LncRNAs-Regulated High Expression of LAMC2 Reveals a Prognostic and Immunological Value in Pancreatic Adenocarcinoma. DOI 10.1007/s10528-023-10435-4 ↗
Yunbao Xu · 1 shared paper, 2021 · strength 0.13
- Paper The role of FOLFIRINOX in metastatic pancreatic cancer: a meta-analysis. DOI 10.1186/s12957-021-02291-6 ↗
Jiaze Hong · 1 shared paper, 2021 · strength 0.13
- Paper The role of FOLFIRINOX in metastatic pancreatic cancer: a meta-analysis. DOI 10.1186/s12957-021-02291-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.